1. Name and Address of Reporting Person*
UNIT 3002-3004, 30TH FLOOR |
GLOUCESTER TOWER, THE LANDMARK, CENTRAL |
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
MedAvail Holdings, Inc.
[ MDVL ]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
3. Date of Earliest Transaction
(Month/Day/Year) 04/04/2022
|
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Form filed by One Reporting Person |
X |
Form filed by More than One Reporting Person |
|
1. Name and Address of Reporting Person*
UNIT 3002-3004, 30TH FLOOR |
GLOUCESTER TOWER, THE LANDMARK, CENTRAL |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
UNIT 3002-3004, 30TH FLOOR |
GLOUCESTER TOWER, THE LANDMARK, CENTRAL |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
UNIT 3002-3004, 30TH FLOOR |
GLOUCESTER TOWER, THE LANDMARK, CENTRAL |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
UNIT 3002-3004, 30TH FLOOR |
GLOUCESTER TOWER, THE LANDMARK, CENTRAL |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
UNIT 3002-3004, 30TH FLOOR |
GLOUCESTER TOWER, THE LANDMARK, CENTRAL |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
UNIT 3002-3004, 30TH FLOOR |
GLOUCESTER TOWER, THE LANDMARK, CENTRAL |
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
430 PARK AVENUE, 12TH FLOOR, |
|
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
1. Name and Address of Reporting Person*
430 PARK AVENUE, 12TH FLOOR, |
|
(Street)
Relationship of Reporting Person(s) to Issuer
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
|
Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. By: ABG-WTT Global Life Science Capital Partners GP, L.P., its general partner By: ABG-WTT Global Life Science Capital Partners GP Limited, its general partner By: /s/ Fan Yu, Director |
04/06/2022 |
|
ABG-WTT Global Life Science Capital Partners GP, L.P. By: ABG-WTT Global Life Science Capital Partners GP Limited, its general partner By: /s/ Fan Yu, Director |
04/06/2022 |
|
ABG-WTT Global Life Science Capital Partners GP Limited By: /s/ Fan Yu, Director |
04/06/2022 |
|
Ally Bridge MedAlpha Master Fund L.P. By: Ally Bridge MedAlpha General Partner L.P., its general partner By: Ally Bridge MedAlpha GP, LLC, its general partner By: /s/ Fan Yu, Manager |
04/06/2022 |
|
Ally Bridge Group (NY) LLC By: ABG Management Ltd., its managing member By: /s/ Fan Yu, Director |
04/06/2022 |
|
ABG Management Ltd., By: /s/ Fan Yu, Director |
04/06/2022 |
|
ABG WTT-MedAvail Limited By: /s/ Charles Chon, Director |
04/06/2022 |
|
/s/ Fan Yu |
04/06/2022 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |